Capital moves, contract wins and AI product pushes drove a busy week across small and mid-cap technology stocks. Hydrix, Complii and ClearVue led the board, while investors sold names where early excitement gave way to dilution concerns or softer earnings detail.
- Hydrix surged after raising cash, converting debt and landing a defence contract.
- Complii jumped on a two-year institutional software deal that opens a new customer segment.
- ClearVue rallied on both a new Cyprus contract and product certification.
- Investors rewarded recurring software revenue and buybacks, but cut stocks hit by dilution or weaker profit detail.
- Defence, cyber security and AI-related announcements remained the busiest parts of the tech board.
Hydrix (ASX:HYD) topped the week with a 127.94% jump after it raised $3.89 million, converted $5.1 million of debt into shares and added a $1.2 million defence contract. Investors cared because the company reduced pressure on its balance sheet and gave itself more cash to operate. Complii FinTech Solutions (ASX:CF1) climbed 47.06% after signing a two-year deal with a major financial institution. That mattered because it moved the company into a larger customer group. ClearVue Technologies (ASX:CPV) rose 40.00% as buyers responded to two pieces of news: a A$305,000 solar glazing contract in Cyprus and a key product certification for its junction box.
Cash, contracts and balance sheets
Several of the strongest moves came from companies that either brought in cash or proved they could sell their product now, not later. Dataworks (ASX:DWG) gained 34.69% after launching its BetGuard self-exclusion system in Ontario. The stock kept rising after it reopened, which suggests buyers were still stepping in rather than taking quick profits. FirstWave Cloud Technology (ASX:FCT) added 33.33% after confirming it had handled disclosure of its $1.85 million Services Australia deal correctly. That response appeared to calm fears about compliance and kept attention on the government contract itself. Infotrust (ASX:ITS) advanced 22.54% after appointing Paul Timmins as chief executive and guiding to $2.3 million in second-half underlying EBITDA. In simple terms, EBITDA is a rough measure of operating profit before some accounting items. Catapult Sports (ASX:CAT) rose 21.43% as revenue and management EBITDA hit records, even though the company still posted a net loss. Investors looked through the loss because much of the damage came from acquisition costs and non-cash charges, which are accounting expenses rather than money paid out that week.Software groups kept selling subscriptions
Larger software names mostly delivered steadier, lower-volatility gains. TechnologyOne (ASX:TNE) climbed 4.02% after posting record half-year profit and annual recurring revenue. Recurring revenue means customers keep paying each year, which investors usually value because it is easier to predict. Serko (ASX:SKO) gained 9.58% after income rose 34% and its US AI beta went live. Vista Group (ASX:VGL) added 8.41% on a six-year cloud deal with Cinépolis Mexico, while RAS Technology (ASX:RTH) rose 5.79% after new deals worth at least $2 million in annualised revenue. Life360 (ASX:360) slipped 0.70% even after announcing a US$225 million multi-year buyback. A buyback means the company plans to buy back its own shares, which can help limit dilution from staff share awards. The mild move suggests the announcement was supportive, but not enough to drive a major rerating on its own.Where early gains faded
Not every strong headline held up. Dotz Nano (ASX:DTZ) fell 10.87% despite appointing a new chief executive and raising A$3.3 million, with the incoming CEO investing more than A$1 million personally. The stock reopened higher, then those gains evaporated. Investors often react this way when fresh capital is raised at a low price because new shares can dilute existing holders. HIQ (ASX:HIQ) finished flat for the week, but after reopening it dropped 16.67%. That points to a similar pattern. The Victorian grant was positive, but some traders still sold into the news. Gentrack (ASX:GTK) lost 8.88% after reporting stable revenue but a sharp EBITDA fall and flagging project delays. In plain English, revenue held up, but profit weakened because work slipped and spending stayed high. The stock also fell further after reopening, which suggests investors were more worried about the earnings dip than excited by the buyback and acquisitions. Vection Technologies (ASX:VR1) dropped 11.11% even after booking $1.1 million in new orders. That looks like a case where the contract value was not large enough to overcome broader doubts about growth pace or delivery.Defence, AI and specialist tech stayed active
Defence-linked technology remained a reliable source of announcements. Codan (ASX:CDA) eased 0.84% after agreeing to buy anti-jamming intellectual property from Adaptive Dynamics for about $21 million. The deal was pitched as earnings neutral in year one, which may explain the muted response. Micro-X (ASX:MX1) fell 2.17% despite a US Department of Homeland Security extension worth US$0.9 million. The contract keeps its airport self-screening project moving, but investors likely want proof of real-world deployment before paying more. Elsewhere, Appen (ASX:APX) ended flat after reporting growth helped by generative AI work and a strong rebound in China. dorsaVi (ASX:DVL) was unchanged after clearing a materials step needed for future RRAM chip production. RRAM is a type of memory used in low-power electronics. Swift TV (ASX:STV) was also flat despite expanding a recurring aged-care rollout, while ION Video (ASX:IOV) rose 11.43% on the appointment of former Apple executive Kelli Richards to its advisory board. Strategic Elements (ASX:SOR) slipped 10.26% after launching a share purchase plan, another sign that investors stayed wary of new equity issues even when the funds are earmarked for product development.Bottom Line?
The next stretch will turn on whether this week’s contract wins convert into repeat revenue, whether capital raisings settle without more selling, and whether upcoming integration work at acquisitive groups starts to lift profit rather than just revenue.
Questions in the middle?
- Can Hydrix turn its stronger balance sheet into repeat defence orders, or was this week’s contract a one-off boost?
- Will Complii’s institutional customer lead to more large clients, or will adoption stay slow in a tightly controlled part of finance?
- After the selling in Gentrack and Dotz Nano, what evidence will investors need before they start buying these names again?